Southpoint Capital Advisors LP

Southpoint Capital Advisors LP is listed in filings as 10% Owner at Fennec Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Dec 29, 2025, including sale activity. Recent filings connect the profile to Fennec Pharmaceuticals Inc. (FENC). The current snapshot covers public activity from Oct 9, 2025 to Dec 29, 2025. Reported amounts are shown as $192.6K to $257.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.